AllDocs -> cancers

« cancers »
by www.alldocs.info
the most recent document references on :: cancers

Web	cancers.alldocs.info

Languages:

Found 1884 documents Page 15 of 63 Pages: << < 10 11 12 13 14 15 16 17 18 19 20 > >>

cancers

ovarian cancer

homepage

www.alldocs.info

Legenda:

last week

last month

[421] A5 Ovarian Cancer IFP.qxd

[120,7 KB] From [www.nice.org.uk] Last viewed: 25.06.2006

Issue date: May 2005 Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan as chemotherapy drugs for the second-line (and subsequent) treatment of advanced ovarian cancer Understanding NICE guidance – information for people with advanced ovarian cancer , their families and carers, and the public Information about Technology Appraisal 91 Page 2 Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan as chemotherapy drugs for the second-line (and subsequent) treatment of advanced ovarian cancer Ordering information Ordering information You can download the following documents from www.nice.org.uk/TA091: ? this booklet ? the full guidance on this appraisal ? a short version for health professionals – the ...

[422] Ovarian Cancer

[185,1 KB] From [www.wellbeingofwomen.org.uk] Last viewed: 25.06.2006

Ovarian Cancer Page 2 WellBeing of Women Funding Vital Health Research WellBeing of Women is about life – helping enable it, sustain it and make it the best quality. Women are the motivating factor for us and our aim is for women everywhere to be free of fear and suffering from reproductive problems. Our determination to meet the health needs of women today is as strong as it was in 1964 when the charity started. WellBeing of Women is dedicated to the challenge of raising greater awareness and securing more support and funds to invest in new medical research in three key areas of reproductive health: G Gynaecological Cancers G Pregnancy and Birth G Quality of Life problems If you would like to know more about WellBeing of Women , please contact us at: WellBeing of Women 27 Sussex Place ...

[423] High plasma YKL-40 level in patients with ovarian cancer stage III ...

[32,2 KB] From [147.52.72.117] Last viewed: 25.06.2006

Abstract. YKL-40 (human cartilage glycoprotein-39) is a member of family 18 glycosyl hydrolases. YKL-40 is a growth factor and is secreted by cancer cells. High serum levels of YKL-40 in patients with colorectal cancer and recurrent metastatic breast cancer have been associated with a poor prognosis. We evaluated the prognostic value of plasma YKL-40 in patients with primary ovarian cancer (OC). YKL-40 was determined by ELISA in plasma obtained preoperatively from 47 women with stage III OC and in plasma from 79 healthy females. The results showed that plasma YKL-40 was elevated compared to healthy females in 57% of the OC patients and was highest in the patients who died during the follow-up compared to the patients still alive (186 vs. 78 µ g/l, p=0.002). Patients with high plasma YKL-40 (>130 µ g/l) had significantly (p=0.0003) shorter survival than patients with normal plasma YKL-40. ...

[424] MOLECULAR GENETIC ALTERATIONS IN OVARIAN CANCER - The Role of the ...

[5259,2 KB] From [edoc.hu-berlin.de] Last viewed: 25.06.2006

cancer 1581 Chemoprevention of Prostate Cancer Amanda Cashen, M.D. Oncology Grand Rounds September 5, 2003 Cancer chemoprevention: Definition The use of agents to inhibit, delay, or reverse carcinogenesis From Clin Cancer Res, 2002; 8:314 Principles of Chemoprevention: Multistep Carcinogenesis Principles of Chemoprevention: Field Carcinogenesis Patients at risk for epithelial cancer have a wide area of carcinogenic tissue change Gross premalignant lesions (leukoplakia, polyps) Metaplasia, dysplasia Molecular changes (gene loss/amplification) Multifocal, distinct premalignant lesions can progress over a “field” of tissue Chemoprevention can affect the whole field ...

[425] Biomarker Modulation in a Nonhuman Rhesus Primate Model for ...

[153,8 KB] From [www.bme.arizona.edu] Last viewed: 25.06.2006

Biomarker Modulation in a Nonhuman Rhesus Primate Model for Ovarian Cancer Chemoprevention 1 Molly Brewer, 2 Urs Utzinger, William Satterfield, Lori Hill, David Gershenson, Robert Bast, J. Taylor Wharton, Rebecca Richards-Kortum, and Michele Follen Departments of Gynecologic Oncology [M. B., D. G., J. T. W., M. F.], Veterinary Sciences Science Park [W. S., L. H.], and Medicine [R. B.], University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; Department of Obstetrics, Gynecology and Reproductive Science, University of Texas Medical School, Houston, Texas 77030 [M. B., M. F.]; and Biomedical Engineering Program, University of Texas at Austin, Austin, Texas 78712 [U. U., R. R-K.] Abstract Objective: The objective of this study was to explore whether a nonhuman primate model could be developed to test drugs for the prevention ...

[426] Differential Susceptibility to Etoposide in Clones Derived from a ...

[7,9 KB] From [content.karger.com] Last viewed: 25.06.2006

Abstract. Antizyme is a negative regulator of cellular poly- amines. The gene for antizyme ( OAZ1 ) is mapped to 19p13.3, where frequent allelic imbalance (AI) is observed in ovarian cancer . The potential role of antizyme 1 in ovarian carcino- genesis was addressed in this study. Mutations of the OAZ1 gene, including the entire coding region and associated promoter region, were examined in 50 primary ovarian tumors and 8 ovarian cancer cell lines by PCR-SSCP and sequencing analyses. A missense mutation in exon 1 and a nucleotide change at the 3'-UTR were detected in an ovarian cancer cell line and its derivative cisplatin resistant cell line. No somatic mutation was detected in primary ovarian tumors, although 7 polymorphic sites were identified. AI of the OAZ1 gene was detected in 7 of 30 informative cases of primary ovarian cancer (23%). Subsequent multiplex fluorescent microsatellite ...

[427] Honoring National Ovarian Cancer Awareness Month Is September 2005,

[6,8 KB] From [pdfserver.prweb.com] Last viewed: 25.06.2006

Honoring National Ovarian Cancer Awareness Month Is September 2005, Teal We Meet Again Announces Its Commitment to Raise Awareness Teal We Meet Again offers free shipping on all products in September. Plano, TX (PRWEB) September 2, 2005 -- September is National Ovarian Cancer Awareness month and Teal We Meet Again ( http://www.tealwemeetagain.com ) invites you to help them support the cause. In honor of National Ovarian Cancer Awareness month, Teal We Meet Again is offering free domestic shipping on all products through the month of September. Teal We Meet Again is the home of handmade soap in the fragrance that was created especially for their Fragrance for a Cause line, Whispering Angels. A new line of soaps was launched this year called Inspiration Soaps, reminiscent of stones, there are eight soaps in the line inscribed with words of inspiration. You can also find handmade Swarovski crystal ...

[428] Altered phosphorylation of topoisomerase I following ...

From [article.pubs.nrc-cnrc.gc.ca] Last viewed: 25.06.2006

Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer S. Makhija, a, * A. Sit, b R. Edwards, b K. Aufman, b H. Weiss, c A. Kanbour-Shakir, d W. Gooding, e G. D’Angelo, e R. Ferrell, f S. Raja, g and T.E. Godfrey g a Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA b Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee–Women’s Hospital and Magee–Womens Research Institute, Pittsburgh, PA 15213, USA c Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35233, USA d Department of Pathology, Magee–Women’s Hospital and Magee–Women’s ...

[429] MB1013 OriGene TissueScan Ovarian Cancer Matched TMA

From [www.cytomyx.com] Last viewed: 25.06.2006

MB1013 OriGene TissueScan Ovarian Cancer Matched TMA 1 2 3 4 5 6 7 8 9 10 11 12 Ovary Ovary Ovary Ovary Ovary Ovary Ovary Ovary Ovary Ovary Ovary Ovary Normal Normal Normal Normal Normal Normal Normal Tumor Tumor Tumor Tumor Tumor A CU0000005619 CI0000008705 CI0000000027 CI0000008510 CI0000010025 CI0000010025 CU0000006486 CI0000008190 CI0000000453 CI0000008501 CI0000009464 CI0000009760 HE HE HE HE HE HE HE HE HE HE HE HE Ovary Ovary Ovary Ovary Ovary Ovary Ovary Ovary Ovary Ovary Ovary Ovary Tumor Tumor Tumor Tumor Tumor Tumor ...

[430] MB59 Ovarian Cancer Array

From [www.cytomyx.com] Last viewed: 25.06.2006

MB59 Ovarian Cancer Array 1 2 3 4 5 Ovary Ovary Ovary Ovary Ovary Tumor Tumor Tumor Tumor Tumor A CI0000000069 CI0000000097 CI0000000085 CI0000000125 CI0000000208 HE HE HE HE HE Ovary Ovary Ovary Ovary Ovary Tumor Tumor Tumor Tumor Tumor B CI0000000210 CI0000000417 CI0000000453 CI0000000476 CI0000000485 HE HE HE HE HE Ovary Ovary Ovary Ovary Ovary Tumor Tumor Tumor Tumor Tumor C CI0000005047 CI0000005554 CI0000005666 CI0000005761 CI0000005939 HE HE HE HE HE Ovary Ovary Ovary Ovary Ovary Tumor Tumor Tumor Tumor Tumor ...

[431] Ovarian Cancer Researcher Honored

[28,4 KB] From [www.ovariancancer.org] Last viewed: 17.06.2006

[432] Ovarian cancer

[189,1 KB] From [www.moh.govt.nz] Last viewed: 17.06.2006

[433] Have fun while raising money for MOCA Ovarian cancer affects 1 in ...

[807,3 KB] From [www.mnovarian.org] Last viewed: 17.06.2006

[434] Ovarian Cancer Survivors Retreat September 8-12, 2005

[86,6 KB] From [campdream.org] Last viewed: 17.06.2006

[435] Ciphergen reports positive results from multi-center validation ...

[95,5 KB] From [www.ciphergen.com] Last viewed: 17.06.2006

[436] The Effect of Age at First Menstruation on Ovarian Cancer Development

[14,1 KB] From [www.usc.edu] Last viewed: 17.06.2006